Investment Strategies
Cutting Concentration Risk By Seeking Wider Opportunities Is "Working" – Schroders

The UK wealth manager talks about how it thinks the approach of seeking opportunities beyond established US large cap stocks is showing its value.
Widening the range of investments to reduce concentration risk in
portfolios is working, Schroders says.
After a period in which market leadership was unusually
concentrated among a handful of US large firms, opportunities are
emerging across a wider range of asset classes, sectors and
regions, according to Dorian Carrell, who heads the multi-asset
group at the UK-based wealth and asset manager, said in a
note.
“Accommodative policy, sufficient easing in geopolitical tensions
and continued strength in artificial intelligence (AI)-related
growth are helping to create a more supportive backdrop for
diversified investors,” Carrell said.
Concentration risk, and how to mitigate risks from it, has been a
theme in wealth management for some time, evidenced by how the
“Magnificent Seven” mega-cap tech stocks, such as Google, Amazon,
Apple and Nvidia drove a disproportionate share of overall equity
market returns. In his note, Schroders’ Carrell said that while a
broadening of opportunities does "not mean that risks have
disappeared. Beneath the surface, there are still potential
icebergs to navigate.”
“Sticky inflation, fiscal deficits and rising Treasury supply
continue to put pressure on the long end of bond markets. Energy
security remains fragile, while the extraordinary pace of AI
investment is raising questions around capital intensity, free
cash flow, financing structures and intensifying competition,”
Carrell said.
While US corporate earnings' growth remains impressive, it
is also exceptionally concentrated. A relatively small group of
companies continues to account for a disproportionate share of
that growth, leaving headline market performance heavily
dependent on expectations being met by a narrow set of
businesses.
Concentration risk is a regular topic. At the SALT conference in
London, an investment panel moderated by this publication
yesterday, heard that it is difficult to avoid the issue because
Big Tech firms, such as AI-related “hyperscalers,” have
delivered such stellar returns. That said, diversification is an
ever-present issue for wealth managers in the medium term, given
an understanding of past business cycles. (See related
commentaries about concentration risk
here, here
and
here.)
Vortex
“Those expectations have created what we see as a valuation
vortex,” Carrell said. “Strong performance attracts capital,
which supports higher valuations and increasingly ambitious
forecasts, drawing in still more capital. This dynamic can
persist, especially while earnings remain supportive. But it also
raises the potential cost of disappointment, as elevated
valuations leave less room for companies to fall short of market
expectations,” he continued.
“This does not mean we are turning away from technology. Agentic
AI continues to capture headlines, and we believe the development
of AI systems capable of completing increasingly complex tasks
could create significant opportunities. However, the investment
implications are unlikely to be confined to the current market
leaders. As adoption expands, opportunities should emerge across
the infrastructure, software and services needed to deploy AI, as
well as among companies able to use the technology to improve
productivity or develop new sources of revenue,” he
said.
Investors should focus on details around the AI investment
cycle.
“Capital expenditure is rising rapidly, putting pressure on free
cash flow, while off-balance-sheet and circular financing
arrangements may make the true scale and distribution of risk
more difficult to assess. Intensifying competition from open
models could also challenge assumptions about pricing power and
the returns ultimately generated from today’s investment,” he
said.
Carrell said he regards healthcare remains as one of Schroders’
preferred diversifiers, given its relatively low correlation with
the broader equity market.
Earnings data in the healthcare sector show that earnings are at
the strongest level since 2021.
The “broadening” thesis also supports some redeployment of
capital outside the US stock market.
“Within equities, we continue to tilt towards international
markets, where valuations are generally less demanding and market
performance is less reliant on a narrow group of companies.
“We favour banks and commodities in particular. Banks can benefit
from a more supportive earnings environment where interest rates
remain above the exceptionally low levels seen during the
previous cycle. Commodity-related companies, meanwhile, provide
exposure to areas where supply discipline, infrastructure
investment and energy-security priorities can support returns,”
he added.